Sverica Capital Management LP (“Sverica”) today announced that it had acquired a majority interest in Gener8, LLC (“Gener8”).
Gener8, founded in 2002, is a leading provider of turnkey design and manufacturing services specializing in high complexity products, primarily for medical device, diagnostics and industrial applications.
Gener8 maintains state-of-the-art facilities and a world-class engineering team with more than 30 PhDs spanning a multitude of disciplines, including electrical, mechanical, software, optical and systems engineering.
For more information, please visit www.gener8.net.
Sverica is a leading lower-middle-market-focused private equity firm that has raised over $700 million of investment capital across four funds.
The firm acquires and actively builds companies that are, or could become, leaders in their industries.
Since 2001, Sverica has maintained a “high touch” operating philosophy of taking an active role in portfolio companies.
For more information, please visit www.sverica.com.
Several gunshots were fired from a vehicle at the U.S. embassy in the Turkish capital, Ankara, on Monday, hitting a window in a security cabin but causing no casualties, police and broadcaster CNN Turk reported.
The attack coincided with a deepening row between Ankara and Washington over the trial of a U.S. pastor in Turkey.
Police teams were searching for the assailants, who fled in a white car after the attack, CNN Turk said.
Four or five gunshots were heard, it said.
Broadcaster Haberturk showed police teams inspecting one of the entrances to the embassy and apparent damage caused by a gunshot could be seen in one window.
It said empty cartridges were found at the scene.
The U.S. embassy in Ankara and the consulate in Istanbul have been the targets of attacks by militants and have faced numerous security threats in the past.